Bartkowiak Joanna, Agarwal Vratika, Otero Diana, Pinheiro Rezende Carolina, Hahn Rebecca T
Department of Medicine, The New York-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
Department of Medicine, The New York-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA; University of California, San Diego, California, USA.
JACC Case Rep. 2025 Mar 19;30(6 Pt 2):103287. doi: 10.1016/j.jaccas.2025.103287.
Heart failure with preserved ejection fraction (HFpEF) and tricuspid regurgitation are increasingly recognized as interrelated conditions with overlapping management approaches.
A 69-year-old woman presented with worsening palpitations and exertional dyspnea. Her symptoms, in combination with a preserved ejection fraction and evidence of increased left ventricular filling pressures, were indicative of HFpEF. Echocardiographic examination revealed torrential tricuspid regurgitation. Guideline-directed medical therapy was optimized, resulting in improvement of tricuspid regurgitation severity.
Recent guidelines for HFpEF management emphasize the use of diuretics for symptom control and the addition of sodium-glucose cotransporter 2 inhibitors and sacubitril-valsartan to improve outcomes. The case underscores the importance of addressing the underlying hemodynamic contributors to tricuspid regurgitation before considering surgical or catheter-based interventions.
TAKE-HOME MESSAGES: Guideline-directed medical therapy for HFpEF plays a crucial role in symptom relief, improves outcomes, and may help reduce tricuspid regurgitation severity.
射血分数保留的心力衰竭(HFpEF)和三尖瓣反流越来越被认为是相互关联的疾病,治疗方法有重叠。
一名69岁女性因心悸和劳力性呼吸困难加重就诊。她的症状,结合保留的射血分数和左心室充盈压升高的证据,提示为HFpEF。超声心动图检查显示重度三尖瓣反流。优化了指南指导的药物治疗,三尖瓣反流严重程度得到改善。
最近关于HFpEF管理的指南强调使用利尿剂控制症状,并加用钠-葡萄糖协同转运蛋白2抑制剂和沙库巴曲缬沙坦以改善预后。该病例强调了在考虑手术或导管介入治疗之前,解决导致三尖瓣反流的潜在血流动力学因素的重要性。
指南指导的HFpEF药物治疗在缓解症状方面起着关键作用,可改善预后,并可能有助于降低三尖瓣反流严重程度。